## Supplementary Figures

![**Receptor quantification and gating of PBMC-derived immune cell types. A&B) Gating for fixed T~helper~ and T~reg~ cells during pSTAT5 quantification. C&D) Fixed CD8+ T cell and NK cell gating. E&F) Gating for live T~helper~ and T~reg~ cells during receptor quantification. G) Live cell NK cell gating. H) Live cell CD8+ cell gating. I) Receptor quantification for each cell type. J) IL-2Rɑ/IL-2Rβ correlation for T~reg~ cells. K) IL-2Rɑ/IL-2Rβ correlation for T~reg~ cells.](./output/figureS1.svg){#fig:S1 tag="S1"}

![**Signaling heterogeneity is explained by multivalent binding model.** A) .](./output/figureS2.svg){#fig:S2 tag="S2"}

![**Complete dose-response curves for all cell types and ligands.** Experimental pSTAT5 measurements are represented by dots. Predicted pSTAT5 responses are shown represented by lines.](./output/figureS3.svg){#fig:S3 tag="S3"}
